These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3924845)

  • 1. Increased synthesis of fibrinolytic inhibitor induced by muramyl dipeptide derivatives in human cultured endothelial cells.
    Dosne AM; Dubor F; Terrier M; Dupuy E; Chedid L
    Int J Immunopharmacol; 1985; 7(2):225-30. PubMed ID: 3924845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of polymyxin B and colimycin on induction of plasminogen antiactivator by lipopolysaccharide in human endothelial cell culture.
    Dubor F; Dosne AM; Chedid LA
    Infect Immun; 1986 Jun; 52(3):725-9. PubMed ID: 3011672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of human endothelial cells by synthetic muramyl peptides: production of colony-stimulating activity (CSA).
    Galelli A; Dosne AM; Morin A; Dubor F; Chedid L
    Exp Hematol; 1985 Dec; 13(11):1157-63. PubMed ID: 3877645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopharmacological activities and clinical development of muramyl peptides with particular emphasis on murabutide.
    Bahr GM; Darcissac E; Bevec D; Dukor P; Chedid L
    Int J Immunopharmacol; 1995 Feb; 17(2):117-31. PubMed ID: 7544767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endotoxin induction of an inhibitor of plasminogen activator in bovine pulmonary artery endothelial cells.
    Crutchley DJ; Conanan LB
    J Biol Chem; 1986 Jan; 261(1):154-9. PubMed ID: 3079753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor.
    Nachman RL; Hajjar KA; Silverstein RL; Dinarello CA
    J Exp Med; 1986 Jun; 163(6):1595-600. PubMed ID: 3086483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of endogenous pyrogen-induced fever by a muramyl dipeptide derivative.
    Parant M; Riveau G; Parant F; Chedid L
    Am J Physiol; 1984 Sep; 247(3 Pt 1):C169-74. PubMed ID: 6476105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minactivin expression in human monocyte and macrophage populations.
    Stephens RW; Golder JP; Fayle DR; Hume DA; Hapel AJ; Allan W; Fordham CJ; Doe WF
    Blood; 1985 Aug; 66(2):333-7. PubMed ID: 3926024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation by muramyl dipeptide (MDP) of the lymphoproliferative responses and polyclonal activation of human peripheral blood mononuclear cells.
    Bahr GM; Modabber FZ; Morin A; Terrier M; Eyquem A; Chedid L
    Clin Exp Immunol; 1984 Jul; 57(1):178-86. PubMed ID: 6744667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium.
    van Hinsbergh VW; Bertina RM; van Wijngaarden A; van Tilburg NH; Emeis JJ; Haverkate F
    Blood; 1985 Feb; 65(2):444-51. PubMed ID: 3917696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in proinflammatory activity of several immunomodulatory derivatives of muramyl dipeptide (MDP) with special reference to the mechanism of the MDP effects.
    Zídek Z
    Agents Actions; 1992 May; 36(1-2):136-45. PubMed ID: 1414682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The immunomodulating activity of new muramyl dipeptide derivatives in vitro].
    Medvedev AE; Fuks BB; Bovin NV; Zemliakov AE
    Biull Eksp Biol Med; 1992 Dec; 114(12):626-8. PubMed ID: 1292694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereo-isomer specific induction of renal cell apoptosis by synthetic muramyl dipeptide (N-acetylmuramyl-L-alanyl-D-isoglutamine).
    Langford MP; Chen D; Welbourne TC; Redens TB; Ganley JP
    Mol Cell Biochem; 2002 Jul; 236(1-2):63-73. PubMed ID: 12190122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor (TNF) stimulates plasminogen activator inhibitor (PAI) production by endothelial cells and decreases blood fibrinolytic activity in the rat.
    Dosne AM; Dubor F; Lutcher F; Parant M; Chedid L
    Thromb Res Suppl; 1988; 8():115-22. PubMed ID: 3144762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minactivin: a human monocyte product which specifically inactivates urokinase-type plasminogen activators.
    Golder JP; Stephens RW
    Eur J Biochem; 1983 Nov; 136(3):517-22. PubMed ID: 6416839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease in pyrogenicity of muramyl dipeptide after coupling with luteinizing hormone-releasing hormone.
    Riveau G; Hosmalin A; Carelli C; Lefrancier P; Chedid L
    J Leukoc Biol; 1988 Nov; 44(5):448-54. PubMed ID: 3053952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Muramyl dipeptide and its synthetic analog as possible inducers of interleukin-2 production].
    Malaĭtsev VV; Bogdanov IM; Sukhikh GT; Andronova TM
    Biull Eksp Biol Med; 1985 Aug; 100(8):221-3. PubMed ID: 3875372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of natural killer activity by muramyl peptides: relationship with adjuvant and anti-infectious properties.
    Le Garrec Y; Morin A
    Nat Immun Cell Growth Regul; 1987; 6(2):65-76. PubMed ID: 2439906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity.
    Sakata Y; Curriden S; Lawrence D; Griffin JH; Loskutoff DJ
    Proc Natl Acad Sci U S A; 1985 Feb; 82(4):1121-5. PubMed ID: 3871946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The macrophage, target cell of the synthetic adjuvant muramyl dipeptide.
    Fevrier M; Birrien JL; Leclerc C; Chedid L; Liacopoulos P
    Eur J Immunol; 1978 Aug; 8(8):558-62. PubMed ID: 359336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.